The Place of In Vitro Maturation in PCO/PCOS-Reference-Cited by-同舟云学术

The Place of In Vitro Maturation in PCO/PCOS

Published:2018-07-31 Issue: Volume:2018 Page:1-8
ISSN:1687-8337
Container-title:International Journal of Endocrinology
language:en
Short-container-title:International Journal of Endocrinology

Author:

Julania Shital¹^ORCID,Walls Melanie L.²³,Hart Roger³⁴^ORCID

Affiliation:

1. King Edward Memorial Hospital, 374 Bagot Road, Subiaco, WA 6008, Australia

2. Fertility North, Suite 213, Specialist Medical Centre, Joondalup Health Campus, Shenton Avenue, Joondalup, WA 6027, Australia

3. Fertility Specialists of Western Australia, Bethesda Hospital, 25 Queenslea Drive, Claremont, Perth, WA 6010, Australia

4. Division of Obstetrics and Gynaecology, University of Western Australia, King Edward Memorial Hospital, 374 Bagot Road, Subiaco, Perth, WA 6008, Australia

Abstract

In vitro maturation (IVM) of human oocytes is an emerging treatment option for women with polycystic ovary/polycystic ovary syndrome (PCO/PCOS) in addition to the standard in vitro fertilization (IVF) treatment. There has been significant improvements in pregnancy rates with IVM over the last two decades. This article reviews the place of IVM for women with PCO/PCOS, placing an emphasis on the predictors of successful pregnancy, optimization of culture media, IVM protocols, pregnancy rates, and neonatal outcomes following IVM treatment.

Publisher

Hindawi Limited

Subject

Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://downloads.hindawi.com/journals/ije/2018/5750298.pdf

Reference70 articles.

1. The treatment of infertility in polycystic ovary syndrome: a brief update

2. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome

3. Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome

4. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes

5. Dopamine agonists for preventing ovarian hyperstimulation syndrome

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of risk factors in diabetics resulted from polycystic ovary syndrome in women by EDA analysis and machine learning techniques;Computer Methods in Biomechanics and Biomedical Engineering;2023-09-04

2. In vitro egg maturation and in vitro fertilization—an idea whose time has come?;Fertility and Sterility;2023-04

3. In vitro maturation of oocytes as a laboratory approach to polycystic ovarian syndrome (PCOS): From oocyte to embryo;WIREs Mechanisms of Disease;2023-02-13

4. Regenerative Medicine for Polycystic Ovary Syndrome: Stem Cell-Based Therapies and Brown Adipose Tissue Activation;Stem Cell Reviews and Reports;2023-01-12

5. Association between Glucose Consumption and Oocyte Maturation Competence in Mice with Polycystic Ovarian Syndrome;INT J FERTIL STERIL;2022